Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.17 +0.05 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Cost of Revenue (2015 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) posted Cost of Revenue of $3.84 million for Q2 2026, up 37.2% from $2.8 million a year earlier but down 28.6% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Cost of Revenue (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Biocryst Pharmaceuticals was $20.93 million, up 25.5% year-over-year; for FY2025, it came in at $19.08 million, up 55.5% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 65.2% (FY2020 to FY2025).
  • In prior years, Biocryst Pharmaceuticals' Cost of Revenue was $12.27 million in FY2024 (+173.8%), $4.48 million in FY2023 (-30.1%), $6.41 million in FY2022 (-11.4%) and $7.23 million in FY2021 (+366.4%).
  • Quarterly Cost of Revenue has run from a low of $236,000 in Q1 2022 to a high of $9.52 million in Q4 2025 over five years.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last three quarters, with growth averaging 111.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q3 2022, with growth of 499.5%; the weakest was Q1 2022, with a decline of 96.0%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $5.38 million (Q1 2026), $9.52 million (Q4 2025) and $2.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Biocryst Pharmaceuticals 2.09 Bn 1.01 Bn 214.41 Mn 3.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.84 Mn
Mar 31, 2026 5.38 Mn
Dec 31, 2025 9.52 Mn
Sep 30, 2025 2.19 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 4.57 Mn
Dec 31, 2024 6.09 Mn
Sep 30, 2024 3.21 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 1.56 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 894,000.00
Mar 31, 2023 931,000.00
Dec 31, 2022 2.38 Mn
Sep 30, 2022 3.54 Mn
Jun 30, 2022 246,000.00
Mar 31, 2022 236,000.00
Dec 31, 2021 418,000.00
Sep 30, 2021 591,000.00
API Access

Biocryst Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEY